Cancer: Latest News, Top Stories & Analysis

PHILADELPHIA, PA — Geneos Therapeutics announced that two patients with aggressive cancers have achieved long-term survival on its personalized immunotherapy for cancer (PIC) monotherapy, with one patient living more than …

Regional

Context Therapeutics Takes Bold Step with IND Submission for Groundbreaking Cancer Therapy

April 3, 2024April 2, 2024 - by Timothy Alexander

PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) recently announced its submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for CTIM-76. This …